Jakafi

Biotech Firm Incyte Finds The Right Chemistry For Success
Forbes
Tue, 10/10/17 - 10:25 am
Incyte
biotech
Jakafi
Does Incyte Have The Best Cancer Portfolio Among Mid-Cap Biotechs?
Barron's
Tue, 04/11/17 - 10:07 am
Incyte
epacadostat
olumiant
Jakafi
immuno-oncology
What Were Incyte’s Revenue Streams in 3Q16?
Market Realist
Sat, 01/7/17 - 12:38 pm
Incyte
Jakafi
Iclusig
Gilead Fails to Beat Incyte’s Jakafi Drug
Investopedia
Sat, 11/19/16 - 11:32 am
Gilead Sciences
Jakafi
Incyte
momelotinib
myelofibrosis
FDA Grants Breakthrough Therapy Designation for Incyte’s Ruxolitinib (Jakafi®) in Acute Graft-Versus-Host Disease (GVHD)
Yahoo
Fri, 06/24/16 - 09:15 am
FDA
Incyte
Jakafi
breakthrough therapies
graft vs host disease
How Has Incyte’s Jakafi Performed in the US?
Yahoo/Market Realist
Sat, 04/9/16 - 09:31 am
Incyte
Jakafi
Novartis
JAK inhibition for solid tumors flops, forcing Incyte to pull the plug on a slate of trials
Fierce Biotech
Thu, 02/11/16 - 08:58 pm
Incyte
Jakafi
solid tumors
JAK inhibitors
ASCO '15: CTI Biopharma Takes on Myelofibrosis Drug Rival
TheStreet.com
Sat, 05/30/15 - 05:44 pm
ASCO
CTI BioPharma
myelofibrosis
pacritinib
Jakafi
Incyte
Incyte's Jakafi Gets FDA Approval for Polycythemia Vera
Yahoo/Zacks.com
Fri, 12/5/14 - 12:16 pm
Incyte
Jakafi
FDA
polycythemia vera
Incyte Building Blockbuster Drug One Disease At A Time
Investors.com
Mon, 11/17/14 - 04:05 pm
Incyte
Jakafi
myelofibrosis
Geron sells last drug in pipeline to J&J unit
Yahoo/Reuters
Thu, 11/13/14 - 07:14 pm
Geron
JNJ
imetelstat
Jakafi
myelofibrosis
Incyte's Jakafi Unlikely to Benefit Pancreatic Cancer Patients
TheStreet.com
Wed, 06/11/14 - 10:38 am
Incyte
Jakafi
pancreatic cancer
Incyte Gains on Positive Jakafi Data
Yahoo/Zacks.com
Wed, 06/4/14 - 02:53 pm
Incyte
Jakafi
polycythemia vera
ASCO
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
biotech
GED-0301
Celgene
Nogra Pharma
AbbVie
Reata
Bardoxolone
Abbott Labs
Tradjenta
Eli Lilly
Boehringer Ingelheim
FG-4592
AstraZeneca
FibroGen
Pfizer
Bristol-Myers Squibb
Eliquis
Moderna
Forma Therapeutics
dimebon
Medivation
Jakafi
Novartis
Incyte
Incyte Shows Its Path Towards Growth
Seeking Alpha
Thu, 02/13/14 - 09:31 am
Incyte
Jakafi
Incyte Has First-Mover Advantage
Motley Fool
Wed, 10/2/13 - 10:10 am
Incyte
myelofibrosis
Jakafi
Novartis
Myelofibrosis Battle: Novartis Vs. Sanofi
Seeking Alpha
Tue, 09/10/13 - 04:25 pm
Novartis
Sanofi
myelofibrosis
Jakafi
Incyte
SAR302503
This Biotech Has So Many Reasons to Be Liked
Motley Fool
Fri, 09/6/13 - 09:12 am
Incyte
JAK inhibitors
Jakafi
myelofibrosis
Pop-Worthy Data, Incyte, but Let's See More
Motley Fool
Sat, 08/24/13 - 11:42 am
Incyte
Jakafi
pancreatic cancer
Does Incyte Deserve Its New Valuation?
Motley Fool
Thu, 08/22/13 - 09:14 am
Incyte
JAK inhibitors
Jakafi
pancreatic cancer

Pages